Since 2006, the Phospholipid Research Center has been funding research into phospholipid excipients in drugs

Drug Delivery, ParenteralInvestigation and preparation of incretin conjugated nanoemulsions as targeted drug delivery systems

Univ.-Prof. Dr. Andreas Zimmer – University Graz, Austria

Since 2021

Drug Delivery, ParenteralLipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy – part II

Prof. Dr. G. De Rosa, University Frederico II Naples/Italy

Since 2020

Drug Delivery, ParenteralTargeted liposomal drug delivery to pediatric sarcomas: beyond the EPR effect

PD Dr. M. Bernasconi, University of Bern/Switzerland

Since 2020

Drug Delivery, ParenteralBioactive liposomes for the treatment of Non-Alcoholic SteatoHepatitis (NASH)

Assist.Prof. Dr. R. Bansal, University Twente/The Netherlands

Since 2019

Drug Delivery, ParenteralCo-amorphous drug-lecithin systems – bridging the gap between amorphous solid disperions and lipid based drug delivery

Prof. Dr. Dr. h.c. Th. Rades, University of Copenhagen/Denmark

Since 2019

Drug Delivery, OralEnabling oral delivery of peptides by designing phospholipid complexes for self-emulsifying drug delivery systems

Prof. Dr. A. Müllertz, University of Copenhagen/Denmark

Since 2019

Drug Delivery, OralImproving nano-particulate carriers for oral drug delivery using archaeal tetraether lipids from novel sources

Assoc.Prof. Dr. A. Treusch, University of Southern Denmark/Denmark

Since 2019

Drug Delivery, ParenteralLipodisks for dual delivery of chemothereptuic drugs and anticancer peptides

Prof. Dr. K. Edwards, Uppsala University/Sweden

Since 2019

Drug Delivery, OralOral mixed micelle formulations – a novel phospholipid-based platform for safe and effective pediatric drug delivery

Prof. Dr. S. Klein, University of Greifswald/Germany

Since 2019

Drug Delivery, ParenteralTwin-screw extruded phospholipid implants for controlled parenteral delivery

Prof. Dr. R. Bodmeier and Dr. M. Kolbina, FU Berlin/Germany

2019-2021

Drug Delivery, OralDevelopment of phospholipid based depot antimalarial tablets of azadirachta indica leaf extract and artemether/lumefantrine for oral delivery

Prof. Dr. A. A. Attama, University of Nigeria/Africa

Since 2018

Drug Delivery, ParenteralLipid nanovectors to use non-coding RNA oligonucleotides in glioblastoma in combination with standard therapy

Prof. Dr. G. De Rosa, University Frederico II Naples/Italy

2017–2019

Dermal, Drug DeliverySynergy-based delivery system for combating sexually-transmitted bacterial infections: liposomal azithromycin-in-chitosan hydrogel

Assoc. Prof. Dr. Z. Vanić, University Zagreb/Croatia

2017–2018

Depot, Drug Delivery, ParenteralDevelopment of a phospholipid-based depot technology for sustained drug release

Prof. Dr. P. Luciani, University Bern/Switzerland

Since 2016

Basic Research, Dermal, Drug DeliveryInvestigation of liposomal transdermal drug delivery by Raman microscopic imaging in combination with stable isotopic labelling as a new non-invasive modality to study drug penetration

Dr. Ch. Matthaeus, University Jena/Germany

2016-2020

Basic Research, Drug DeliveryOn-demand amplification of chemotherapy by ultra-fast drug release from plasmonic liposomes

Dr. Xiuying Li, University of Dallas/USA

2016–2018

Drug Delivery, ParenteralImproving treatment of pediatric sarcomas through targeted liposomal drug delivery

Dr. M. Bernasconi, University Children’s Hospital Zurich/Switzerland

2015–2017

Drug Delivery, OralElucidating the use of lyso-phospholipids in oral self-nanoemulsifying drug delivery systems

Prof. Dr. A. Müllertz, Copenhagen/Denmark

2013–2017

Drug Delivery, ParenteralA lipid based drug delivery system for CNS applications

Dr. V. Reichel, University of Heidelberg/Germany

2010–2012